Georg-martin M. Haag

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Outcome and prognostic factors in patients undergoing salvage therapy for recurrent esophagogastric cancer after multimodal treatment.

Outcome and prognostic factors in patients undergoing salvage therapy for recurrent esophagogastric cancer after multimodal treatment.

Journal: Journal of cancer research and clinical oncology

Published: February 24, 2022

Hematological Malignancies in Adults With a Family Predisposition.

Hematological Malignancies in Adults With a Family Predisposition.

Journal: Deutsches Arzteblatt international

Published: December 08, 2017

Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1.

Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 24, 2017

Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer - the multinational MATEO study.

Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer - the multinational MATEO study.

Journal: BMC cancer

Published: October 20, 2016

Immunotherapy of Colorectal Cancer.

Immunotherapy of Colorectal Cancer.

Journal: Oncology research and treatment

Published: April 15, 2016

Outcomes and risk factors for cancer patients undergoing endoscopic intervention of malignant biliary obstruction.

Outcomes and risk factors for cancer patients undergoing endoscopic intervention of malignant biliary obstruction.

Journal: BMC gastroenterology

Published: August 13, 2015

Immediate tumor resection in patients with locally advanced gastroesophageal adenocarcinoma with nonresponse to chemotherapy after 4 weeks of treatment versus resection after completion of chemotherapy (OPTITREAT trial, DRKS00004668): study protocol for a randomized controlled pilot trial.

Immediate tumor resection in patients with locally advanced gastroesophageal adenocarcinoma with nonresponse to chemotherapy after 4 weeks of treatment versus resection after completion of chemotherapy (OPTITREAT trial, DRKS00004668): study protocol for a randomized controlled pilot trial.

Journal: Pilot and feasibility studies

Published: May 13, 2015

Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie.

Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 01, 2014

Efficacy and safety of trastuzumab-based therapy in combination with different chemotherapeutic regimens in advanced esophagogastric cancer--a single cancer-center experience.

Efficacy and safety of trastuzumab-based therapy in combination with different chemotherapeutic regimens in advanced esophagogastric cancer--a single cancer-center experience.

Journal: Tumori

Published: July 31, 2014

Treatment of long-term catheter-related bloodstream infections with a taurolidine block: a single cancer center experience.

Treatment of long-term catheter-related bloodstream infections with a taurolidine block: a single cancer center experience.

Journal: The journal of vascular access

Published: November 30, 2010

Showing 1-10 of 10

Last Updated: 09/26/2026